Liuzhong F. Yang
Xinxiang, 453100, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
JYP0322, a highly selective and brain-penetrant ROS1 inhibitor, overcomes ROS1G2032R resistance mutation in NSCLC: The first-in-human phase 1 trial.
Journal: Cancer cell
Published: August 01, 2025
8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial.
Journal: Breast cancer research : BCR
Published: December 17, 2024
Bovine serum albumin-bound homologous targeted nanoparticles for breast cancer combinatorial therapy.
Journal: International journal of biological macromolecules
Published: June 20, 2024
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 02, 2024
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study.
Journal: Cancer communications (London, England)
Published: May 20, 2021
Automatic Machine Learning to Differentiate Pediatric Posterior Fossa Tumors on Routine MR Imaging.
Journal: AJNR. American journal of neuroradiology
Published: November 30, 2019
RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: November 17, 2014
Association of dietary intake of folate and MTHFR genotype with breast cancer risk.
Journal: Genetics and molecular research : GMR
Published: August 01, 2014
PSMA7 directly interacts with NOD1 and regulates its function.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: June 04, 2013
miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma.
Journal: Molecular medicine reports
Published: March 05, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026